WeVote
Log In

Bill

Bill

HB 6561

AN ACT REQUIRING SIDE EFFECT DISCLOSURES ON STATE-FUNDED ADVERTISEMENTS FOR VACCINES.

2025 Regular Session Introduced by Anne Dauphinais and 2 co-sponsors

HB 6561 requires state-funded vaccine ads to disclose potential side effects, with standards and enforcement; it affects state agencies, ad vendors, and the public.

REF. TO JOINT COMM. ON Public Health
#advertising #disclosure #immunization
0
WeVote Research Nonpartisan
Bill Summary · HB 6561

Summary of HB 6561: An Act Requiring Side Effect Disclosures on State-Funded Advertisements for Vaccines

Basic bill information

  • Bill Number: HB 6561
  • Title: AN ACT REQUIRING SIDE EFFECT DISCLOSURES ON STATE-FUNDED ADVERTISEMENTS FOR VACCINES
  • Status: Referral to Joint Committee on Public Health (REF. TO JOINT COMM. ON Public Health)
  • Introduced: January 24, 2025
  • Subject: Advertising, Disclosure, Immunization

Purpose and Intent

  • The bill appears to aim to increase transparency in public health communication by ensuring that side effects are disclosed in advertisements funded by the state that promote vaccines.
  • The underlying intent, as suggested by the title, is to provide the public with information about potential vaccine side effects as part of state-sponsored messaging.

Key Provisions (Note: Text is not provided in the briefing; the following reflects typical elements such a bill might include)

  • Require state-funded vaccine advertisements to include disclosures about potential adverse effects or common side effects associated with the vaccine.
  • Specify the form, content, and placement of disclosures (e.g., language requirements, font size, contrast, duration on screen or in print).
  • Define what constitutes “state-funded advertisements” and which campaigns or channels are covered (e.g., public health campaigns, digital ads, broadcast media, print materials).
  • Establish standards for accuracy and timeliness of disclosed information, potentially tying updates to official vaccine guidance.
  • Provide enforcement or compliance mechanisms (e.g., reporting requirements, audits, penalties for noncompliance) and establish responsible agencies or offices.
  • Include applicability provisions (e.g., which vaccines are covered, any exemptions, transitional timelines for implementation).

Important: Specific text, thresholds, and enforcement details are not provided in the summary you shared. The above enumerates the typical components such a bill might contain.

Affected Parties

  • State agencies and public health departments that run or fund vaccine advertising campaigns.
  • Advertising contractors and vendors engaged to produce state-funded vaccine advertisements.
  • General public and specific communities targeted by vaccine campaigns, who would receive disclosed information.
  • Possible impact on vaccine manufacturers or health providers if the disclosures affect messaging and outreach materials.

Potential Impacts

  • Increased transparency in public health messaging regarding vaccines.
  • Changes to budgeting and contracting for state advertising to accommodate disclosure requirements (e.g., production costs, review processes).
  • Potential effects on public perception of vaccines depending on how disclosures are framed and understood.
  • Administrative workload for compliance, review, and periodic updates to disclosures as vaccine guidance evolves.

Legislative Process and Timeline

  • Current status: Bill introduced and referred to the Joint Committee on Public Health.
  • Next steps: The committee may hold hearings, amend the bill, and vote on whether it should advance to the full chamber(s). If advanced, the bill would proceed through further readings and votes, potentially facing amendments or negotiation in the legislative process.
  • Important dates to watch: Any committee hearing dates, amendments, and floor consideration after committee action.

Summary

HB 6561 seeks to mandate side effect disclosures in state-funded vaccine advertisements. While the exact provisions are not included in the available information, the measure would likely cover disclosure content, implementation standards, and enforcement, affecting state agencies, advertising contractors, and the general public. The bill was introduced on January 24, 2025 and is currently in committee referral to the Public Health committee.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.